US Patent 11634688 Methods and compositions for inducing hematopoietic cell differentiation
Patent 11634688 was granted and assigned to Fate Therapeutics on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 30 Apr, 2023
Golden AI
Edits made to:
Infobox (+37 properties)
Article (+609 characters)
US Patent 11634688 Methods and compositions for inducing hematopoietic cell differentiation
Article
The invention provides culture platforms, cell media, and methods of differentiating pluriptent cells into hematopoietic cells. The invention further provides pluripotent stem cell-derived hematopoietic cells generated using the culture platforms and methods disclosed herein, which enable feed-free, monolayer culturing and in the absence of EB formation. Specifically, pluripotent stem cell-derived hematopoietic cell of this invention include, and not limited to, iHSC, definitive hemogenic endothelium, hematopoietic multipotent progenitors, T cell progenitors, NK cell progenitors, T cells, and NK cells.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116346880
Date of Patent
April 25, 2023
0Patent Application Number
167813600
Date Filed
February 4, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11634688 Methods and compositions for inducing hematopoietic cell differentiation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
